All Updates

All Updates

icon
Filter
Partnerships
Synthego partners with bit.bio to build platform for genetic engineering of human cells for therapies
Human Gene Editing
Aug 24, 2023
This week:
Product updates
Nintendo ventures into MMOs with new Switch Online game playtest
Metaverse Experience Platforms
Yesterday
Product updates
HP releases texture library for 3D printing with CoreTechnologie 4D Additive
Additive Manufacturing
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Smart Factory
Oct 21, 2024
Product updates
xAI launches API for third-party developers to access Grok models
Foundation Models
Oct 21, 2024
Partnerships
Nava Benefits partners with OpenAI to launch AI-powered benefits assistant
Foundation Models
Oct 21, 2024
Product updates
IBM releases Granite 3.0 AI models for enterprise use
Foundation Models
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Foundation Models
Oct 21, 2024
M&A
Inflection AI acquires Boundaryless for undisclosed sum to accelerate enterprise AI deployments
Foundation Models
Oct 21, 2024
Industry news
News Corp sues Perplexity AI for alleged copyright infringement
Generative AI Applications
Oct 21, 2024
Product updates
Haiper debuts new video generation model
Generative AI Applications
Oct 21, 2024
Human Gene Editing

Human Gene Editing

Aug 24, 2023

Synthego partners with bit.bio to build platform for genetic engineering of human cells for therapies

Partnerships

  • Genome engineering company Synthego and precision cell programming company bit.bio have announced a strategic partnership to explore synthetic circuitry implementation in cells for therapeutic purposes.

  • The partnership aims to develop advanced genetic engineering solutions for cell therapies by leveraging Synthego's gene-editing expertise and bit.bio's opti-ox precision cell programming technology to uncover and refine multiplexed genetic editing strategies. This approach has the potential of reducing the number of engineering steps required, and thereby reducing cell development timelines by up to 10 months. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.